# OnCo record qol-pro (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/qol-pro/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "qol-pro" ;
  schema:name "Quality of life and patient-reported outcomes (QoL, PRO)"@en ;
  schema:alternateName "QoL"@en, "QOL"@en, "quality of life"@en, "quality-of-life"@en, "health-related quality of life"@en, "HRQoL"@en, "HRQL"@en, "PRO"@en, "PROs"@en, "patient-reported outcome"@en, "patient-reported outcomes"@en, "patient-reported"@en, "patient reported"@en, "PRO-CTCAE"@en, "EORTC QLQ-C30"@en, "QLQ-C30"@en, "FACT-G"@en, "EQ-5D"@en, "symptom burden"@en, "symptom scores"@en, "functional status"@en, "time to deterioration"@en, "TTD"@en, "global health status"@en, "tolerability endpoints"@en, "patient experience"@en, "financial toxicity questionnaire"@en, "symptom score"@en ;
  schema:description "Measures of how patients themselves feel and function during treatment (pain, fatigue, nausea, daily activities), collected by questionnaire rather than by the doctor. Regulators and payers now expect them alongside survival, and clinician grading is known to under-report symptoms."@en ;
  schema:url <https://onco.cc/terms/qol-pro/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Patient-reported_outcome> ;
  schema:citation <https://en.wikipedia.org/wiki/Patient-reported_outcome>, <https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims> ;
  onco:related <https://onco.cc/terms/ctcae-grading/>, <https://onco.cc/terms/hta/>, <https://onco.cc/terms/ttp/>, <https://onco.cc/terms/financial-toxicity/>, <https://onco.cc/terms/quality-adjusted-survival/>, <https://onco.cc/terms/decentralised-trial/>, <https://onco.cc/terms/n-of-1-trial/>, <https://onco.cc/terms/absolute-benefit/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/drug-discovery/> ;
  onco:technologies <https://onco.cc/technologies/epro-symptom-monitoring/>, <https://onco.cc/technologies/remote-patient-monitoring/> ;
  onco:trials <https://onco.cc/trials/checkmate-9er/>, <https://onco.cc/trials/cctg-ce6/>, <https://onco.cc/trials/quartz/>, <https://onco.cc/trials/mars-2/>, <https://onco.cc/trials/therap/> .